Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Endo’s Generics Add $30m Due To COVID-19 Impact
Company Sees $75m Overall Growth In Q1 From Coronavirus Demand
May 13 2020
•
By
Akriti Seth
Endo’s generics segment saw double-digit growth in the first quarter of 2020 • Source: Shutterstock
More from Strategy
More from Business
